Technology/Clinical Practice Committee (TCPC)

The function of the Technology/Clinical Practice Committee (TCPC) is to ensure that new technologies and clinical practices at Monash Health are introduced within a rigorous and evidence-based framework.

About TCPC

Roles and Responsibilities

The Committee oversees and supports clinicians in the safe and appropriate introduction of a technology or clinical practice that has not previously been undertaken at Monash Health.

Approval must be obtained from the committee before commencing any new technologies or clinical practices on any Monash Health patient.

Once a new technology or clinical practice is approved by the TCPC, it is the responsibility of the head of unit, program director and executive sponsor to oversee the implementation of any technology and clinical practice being introduced.

The TCPC will monitor the progress and patient outcomes of each new application over two years or as determined by the committee. Applicants should submit progress reports and patient outcomes on a six monthly basis upon the commencement of the approved new technology/clinical practice.

Monash Health staff can access policies and procedures for the introduction of new technology and clinical practices here or via PROMPT.

The Terms of Reference of the TCPC is reviewed annually.

 

Meeting Dates

Last updated : 19th October 2021

Meeting DateApplications to be Submitted by
23rd November 20219th November 2021
21st December 20217th December 2021
25th January 202211th January 2022
22nd February 20228th February 2022
22nd March 20228th March 2022
26th April 202212th April 2022
24th May 202210th May 2022
28th June 202214th June 2022
26th July 202212th July 2022
23rd August 20229th August 2022
27th September 202213th September 2022
25th October 202211th October 2022
22nd November 20228th November 2022
20th December 20226th December 2022

New Technology/Clinical Practice (TCP) Application

Definition of a New Technology / Clinical Practice

A new technology or clinical practice is defined as a therapeutic intervention (including prostheses; implantable devices; high cost pharmaceuticals; medical, surgical or other clinical procedures) or diagnostic procedure that is considered by a reasonable body of clinical opinion to be significantly different from existing clinical practice.

Types of new TCP Applications

A: New Technology/Clinical Practice

This application is required when a new technology or clinical practice that has not been performed/utilised at Monash Health is to be introduced.

B: Change of Use of Technology/Clinical Practice

This application is required if there is a significant change to the technology and/or clinical practice that has already been introduced to Monash Health. This would generally refer to:

  • Change or additional indication
  • Including/removal of a particular patient group
  • Change in the approach, technique or equipment design

C: Research Projects involving the use of new Technology/Clinical Practice

This application is required if a research project will involve the use of a new technology and/or clinical practice at Monash Health. The scope of the Committee review will be limited to ensuring that the credentialling, financial and/or operational implications have been considered for the new technology/clinical practice required for the research project. The application will be reviewed in conjunction to a Monash Health Human Research Ethics Committee (HREC) application and will be contingent on a current HREC approval certificate.

    Which application would I need?

 

For further assistance with deciding if an application is required, please contact the TCPC Secretariat.

TCP Application Process

last updated : 19th October 2021

Prior to initiating an application, clinicians are advised to discuss the scope of the application with the TCPC Secretariat.

Step 1Download the relevant pack for your application.

Step 2 – Prepare the documents as outlined in the form.

Step 3 – Submit all relevant documents to TCPC Secretariat. Please refer to the submission cut off dates for consideration at the TCPC Meetings.

Step 4 – Once documents have been received and reviewed, the TCPC Secretariat will contact you within 2 weeks to provide you with a date for you to present your application to the TCP Committee.

Step 5 – Following your presentation, the TCPC Secretariat will be in touch within 2 weeks to inform you of the outcome of your application or if more information is required.

Step 6 – If your application is approved by the TCPC, you will be required to fulfil and adhere to the conditions of the endorsement for the duration outlined in the outcome letter. This would include the providing the Committee regular reports as outlined in reporting requirements for successful TCP Applications.

Download Application Documents

*Please note that the TCPC Secretariat is available at ANY stage of the application process for discussion.

TCP Committee Decision Criteria

Decisions are made considering the best available evidence, are transparent and accountable. The review process includes assessment of the following by the Committee:

  • safety, effectiveness and cost effectiveness
  • operational requirements such as cost, capacity, capability and credentialing
  • considerations related to access, equity, legal and ethical issues
  • review of patient information about the new procedure.

Reporting Requirements for Successful TCP Applications

The Committee monitors the successful outcomes and adverse events of each application over the span of two years (or more depending on the application) following the introduction of a new technology or clinical practice.

Upcoming reporting periods are:

Reporting PeriodDue Dates for Reporting
2021: July – December14 February 2022
2022: January – June15 August 2022
2022: July- December13 February 2022

 

Applicants are to fill out 2 forms and send them to the TCPC Secretariat by the dues dates of each reporting period:

  1. TCPC Progress Report Template
  2. TCPC Patient Outcome Audit Spreadsheet

*Please note that you may also submit the Patient Outcome Audit using your own template.

These reports are then collated and reported to the Monash Health Executive Committee annually.

PLEASE NOTE:

All adverse events related to the new TCP must be reported on RiskMan and to the TCPC Secretariat as soon as possible.

Download Progress Report Templates

Review of Reclassification to Standard Practice

Following the standard two-year monitoring period (or more as outlined in the Conditions of Approval), successful outcomes, added value to patient care and improved clinical and cost effectiveness, applicants may apply for the approved New Technology/Clinical Practice to be reclassified to Standard Practice.

Download Review for Reclassification Application Form

Evaluation of the Technology/Clinical Practice (TCP) Program

The committee invites ongoing feedback about all systems and processes.

A program logic map and evaluation plan were developed to facilitate evaluation of the program.

The program won the 2009 Australian Council of Healthcare Standards Quality Improvement Award for Non-Clinical Service Delivery. It was also nominated for the 2009 Victorian Public Healthcare Award for Most Appropriate Care: providing least intrusive and earliest effective care.

The TCPC was last evaluated in December 2015. A copy of the evaluation report may be requested from the TCPC Secretariat.

 

New Technology/Clinical Practice applications submitted for consideration

The lists below display titles of applications submitted to the TCPC for consideration. This does not indicate if the technology or clinical practice is currently being used in Monash Health.

All decision summaries published are readily available upon request from the TCPC Secretariat.

2020

  • Medrad Centargo CT Contrast Media Power Injector
  • Self Dilatation for benign nonpharyngeal strictures
  • Percutaneous Tibial Nerve Stimulation (PTNS)

2019

  • Transperineal ultrasound for muscle biofeedback
  • Sentinel cerebral embolic protection
  • Migraine surgery
  • Corneal neurotisation
  • Doppler guided haemorrhoid artery ligation with recto-anal repair (HAL-RAR)

2018

  • Vagus nerve stimulation
  • Telemetric measurement of intracranial pressure
  • Per Oral Endoscopic Myotomy (POEM) procedure
  • Transoral thyroidectomy
  • FlexDex needle holder in paediatric urology
  • Transabdominal transanal total mesorectal excision (TATA-TME)
  • Treatment of venous insufficiency using percutaneous a) radiofrequency ablation and b) cyanoacrylate closure
  • Superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery

2017

  • Endometrial-ablation hyperthermia catheter
  • Tunnelled paracentesis for domiciliary ascitic drainage
  • Physiotherapists administering inhaled medications
  • Endoanchors
  • Nutrition and dietetics pathology requesting privileges
  • Intracardiac echocardiography (ICE)

2016

  • Nellix stent graft
  • Cochlear implantation in adults
  • Negative pressure device to treat lymphoedema
  • Micra leadless pacemaker
  • Patient Safety NET Woven EndoBridge (WEB) device for the treatment of complex wide-neck brain aneurysms
  • Hemospray use in non-variceal upper gastrointestinal bleeding
  • Electrical nerve stimulation after peripheral nerve injury repair
  • Coolsense device
  • GDC and PCOS Laser hair removal service

2015

  • Thromboelastograpy
  • ReCell – Autologous cell harvesting device
  • Vertebral augmentation (kyphoplasty) as palliative pain relief procedures in patients with disabling cancer-related spinal column pain
  • Perceval-S Sutureless aortic valve replacement
  • Skeletal distraction of the proximal interphalangeal joint
  • Biojector 2000 – Needle Free Injection System
  • Targeted Intra-operative Radiotherapy (IORT) for breast cancer

Contact information

Book your COVID-19 vaccination -Find out more
+